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Abstract
Background: More than 50% of human genes initiate transcription from CpG dinucleotide-rich regions referred to
as CpG islands. These genes show differences in their patterns of transcription initiation, and have been reported
to have higher levels of some activation-associated chromatin modifications.
Results: Here we report that genes with CpG island promoters have a characteristic transcription-associated
chromatin organization. This signature includes high levels of the transcription elongation-associated histone
modifications H4K20me1, H2BK5me1 and H3K79me1/2/3 in the 5’ end of the gene, depletion of the activation
marks H2AK5ac, H3K14ac and H3K23ac immediately downstream of the transcription start site (TSS), and
characteristic epigenetic asymmetries around the TSS. The chromosome organization factor CTCF may be bound
upstream of RNA polymerase in most active CpG island promoters, and an unstable nucleosome at the TSS may
be specifically marked by H4K20me3, the first example of such a modification. H3K36 monomethylation is only
detected as enriched in the bodies of active genes that have CpG island promoters. Finally, as expression levels
increase, peak modification levels of the histone methylations H3K9me1, H3K4me1, H3K4me2 and H3K27me1 shift
further away from the TSS into the gene body.
Conclusions: These results suggest that active genes with CpG island promoters have a distinct step-like series of
modified nucleosomes after the TSS. The identity, positioning, shape and relative ordering of transcription-
associated histone modifications differ between genes with and without CpG island promoters. This supports a
model where chromatin organization reflects not only transcription activity but also the type of promoter in which
transcription initiates.
Background
More than half of human genes initiate transcription
from regions of the genome with an elevated content of
CpG dinucleotides and G+C base pairs referred to as
‘CpG islands’ [1,2]. In contrast to the rest of the gen-
ome, where CpG dinucleotides are heavily methylated
and so rapidly lost through deamination, CpG sites
within promoter CpG islands are normally free from
DNA methylation and do not have an elevated mutation
rate [3-7]. Genes with promoters containing CpG
islands (henceforth CpG promoter genes) encode house-
keeping genes expressed in all cell types [8-11] but also
include a substantial number of master developmental
regulators such as HOX genes [9,12]. In contrast, non-
CpG promoter genes tend to have more restricted
expression patterns and to be expressed later in devel-
opment during tissue differentiation.
Several lines of evidence suggest that the process of
transcription initiation differs in CpG and non-CpG pro-
moters. Systematic identification of the 5’ ends of mam-
malian transcripts revealed that transcription tends to
initiate from a broad region in CpG promoters but in a
sharp peak in non-CpG promoters [13]. CpG promoters
also more frequently initiate transcription in both the
sense and antisense direction, and produce unstable non-
coding RNAs even in the absence of full-length mRNA
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production [13-16]. Further, RNA polymerase II may be
constitutively recruited to CpG promoters [14,17,18], with
polymerase release being an important point of regulation
[14,19]. CpG promoters are less likely to contain a TATA-
box [13], and contain fewer specifically located transcrip-
tion factor binding sites [20].
In addition to transcription, chromatin organization
has also been reported to differ between CpG and non-
CpG promoters. CpG and GC-rich DNA is preferentially
bound by CXXC domain proteins that can recruit chro-
matin-modifying activities, including Cfp1 [21], a subunit
of an H3K4me3 methyltransferase complex [22], and
KDM2A, a H3K36me2 demethylase [23]. Consistent with
this, unmethylated CpG promoters have higher levels of
H3K4me3, a histone modification associated with tran-
scription initiation [24-27]. However, CpG promoters
also have higher levels of other modifications associated
with transcription activation, such as the histone H3
lysine 4 methylations H3K4me1 and H3K4me2, and the
histone variant H2A.Z [26,27]. Moreover, it has been
reported that GC-rich sequences can recruit the poly-
comb repressive complex 2 [28]. CpG promoters have
also been reported to contain a more pronounced
nucleosome-depleted region upstream of the start site,
despite the fact that nucleosomes have a high intrinsic
affinity for G+C and CpG rich DNA [29]. This distinction
between nucleosome-depleted CpG promoters and
nucleosome occupied non-CpG promoters is reminiscent
of the distinction between two major classes of promoter
in budding yeast [30,31]. Finally, in efforts to use chro-
matin modifications to predict the locations of core pro-
moters or gene expression levels, different modifications
have sometimes been reported as most useful for genes
with and without CpG islands [32,33]. For example, in
the models developed by Karlic et al. [33], H4K20me1
and H3K27ac were most frequently employed to predict
the expression levels of genes with CpG island promo-
ters, whereas H3K4me3 and H3K79me1 were the modifi-
cations most frequently used in models to predict the
expression levels of non-CpG island genes.
Chromatin-modifying enzymes can be recruited by elon-
gating polymerase complexes, by sequence-specific DNA-
binding proteins, and by non-coding RNAs [34]. We
hypothesized, therefore, that, beyond the distinctions
described above, promoter type could be quite a general
influence on the chromatin organization of a gene, includ-
ing distally, away from the start site. We show here that
this is indeed the case, and that genes with CpG island pro-
moters show characteristic transcription-coupled changes
in chromatin organization not seen in other genes. In parti-
cular, CpG promoter genes show a distinct set of transcrip-
tion-linked epigenetic transitions within the 5’ end of their
gene bodies. They also have a different chromatin organi-
zation within the promoter region, including a histone
modification specifically detected at the initiation site. Our
analyses highlight complex differences in the chromatin of
human genes with and without CpG islands in their pro-
moters, and are consistent with a model in which there are
at least two characteristic ways in which the chromatin of a
human gene changes from repression to activation,
depending upon the type of promoter in which transcrip-
tion initiates.
Results
Chromatin profile comparison of expression-matched
genes with and without CpG islands in their promoters
To test whether human genes with CpG island promoters
have a distinct chromatin organization, we analyzed the
levels of histone modifications and other epigenetic modi-
fications in 1,500 CpG and 1,500 non-CpG promoter
genes with precisely matched expression levels (Materials
and methods; Figure 1a; Additional files 1 and 2). Tran-
scription is a strong influence on chromatin organization
[24,33,35-39] and so it is necessary to control for expres-
sion level when examining additional potential influences.
We first analyzed histone modifications previously asso-
ciated with transcription elongation, that is, enriched
within the bodies of expressed genes.
Trimethylation of the lysine 3 residue of histone H3
(H3K36me3) is catalyzed by Set2-type methyltransferases
and is linked to transcription elongation [40-42]. As shown
in Figure 1, CpG and non-CpG promoter genes with
matched expression levels have very similar distributions of
this modification, with a linear accumulation towards the
3’ end of expressed genes, and levels that correlate with
expression (Figure 1b). Only at the first nucleosome down-
stream of the site of initiation do highly expressed non-
CpG promoters show a slightly higher level of this histone
modification. The similar accumulation of H3K36me3
towards the end of the gene suggests a similar transcription
elongation-coupled mechanism of H3K36me3 deposition
in both gene classes.
Transcription elongation-associated histone modifications
peak in the 5’ end of genes with CpG island promoters
In contrast to H3K36me3, however, our analysis revealed
that other histone modifications enriched within the bodies
of active genes have different distributions in CpG and
non-CpG promoter genes. The modification H4K20me1 is
catalyzed by SETD8/Pr-Set7 methyltransferases and has
been variously linked to gene silencing, gene activation,
transcription elongation, and to the early exons of highly
expressed genes [43-47]. In expressed genes with CpG pro-
moters, H4K20me1 levels increase rapidly within gene
bodies, reaching a peak on nucleosomes approximately 1
to 1.5 kb after the start site (Figure 2a). In contrast, in non-
CpG promoter genes, H4K20me1 levels are low on promo-
ter-proximal nucleosomes, increasing only gradually to a
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plateau approximately 2 to 2.5 kb after the start site (Figure
2a). A distinct peak is not observed, and non-CpG promo-
ter genes with medium expression only have very low
levels of H4K20me1 (Figure 2a).
Levels of the transcription elongation-linked modifica-
tions H2BK5me1 and H3K79me1/2/3 also differ
between the two gene classes, and in a manner that is
similar to H4K20me1. Modification levels peak on
nucleosomes 750 bp to 1 kb downstream of CpG pro-
moter genes (Figure 2b, c). In contrast, they show only
weak monotonic enrichment in the bodies of genes
without CpG promoters (Figure 2b, c; Additional file 3).
The exon density (Additional file 4), nucleosome density
(see below) and DNA methylation levels (Additional file 5)
downstream of highly expressed CpG and non-CpG pro-
moters are very similar, and so cannot account for these
differences in the deposition of transcription elongation
marks (Additional file 3). Also, the differences in the chro-
matin profiles remain largely unchanged when a different
CpG island definition is used (Additional file 6 using CpG
islands defined by Hackenberg et al. [48] and Additional
file 7 using the promoter classification of Weber et al.
[25]), when we remove all genes with more than one tran-
scription start site (Additional file 8), or even when we use
an independent set of chromatin data from IMR90 cells
(Additional file 9). Rather, genome-wide analysis suggests
differences in the recruitment or activation of histone
modifying enzymes during the early stages of transcription
elongation in these two gene classes.
Transcription-coupled shifts of histone modification peaks
in the 5’ end of CpG promoter genes
A second class of histone modifications revealed by our
analysis is a set of transcription-associated histone methy-
lations that are enriched in genes with CpG island promo-
ters, but for which the location of the most modified
nucleosomes differs depending upon the expression level
(Figure 3). As for the previously described modifications,
the levels of the methylations H3K9me1, H3K4me2,
H3K4me1 and H3K27me1 increase with expression.
Figure 1 Chromatin profile comparison of expression-matched genes with and without CpG islands in their promoters. (a) Expression
levels of 1,500 expression-matched CpG and non-CpG promoter genes classified as having low, medium and high expression levels (500 genes
of each type in each category). (b) Average H3K36me3 profile between 500 bp upstream and 3 kb downstream of the transcription start site
(TSS) of genes with or without a CpG promoter and with low, medium or high expression levels (color coded as in panel (a). Lines represent the
loess-smoothed average read density shifted by 75 bp to indicate the position of the nucleosome dyad and the grey shading indicates the area
within two standard errors of the predicted loess line.
Figure 2 Sharp increases in H4K20me1, H2BK5me1, and
H3K79me1 modification levels in the bodies of CpG promoter
genes. (a-c) Average profiles of H4K20me1 (a), H2BK5me1 (b) and
H3K79me1 (c) for expression-matched groups of CpG and non-CpG
promoter genes (color-coded as in Figure 1a). Arrows indicate
modification peaks unique to CpG promoter genes. TSS,
transcription start site.
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However, in genes with higher expression, maximum
modification levels are found on nucleosomes located
further into the body of a gene (Figure 3a-h). Indeed, the
+1 nucleosomes of highly expressed genes have lower levels
of these histone methylations than the +1 nucleosomes of
lowly expressed genes (Figure 3i-l). To our knowledge, this
shifting of histone methylation peaks into gene bodies has
not been previously noted.
Monomethylation of H3K36 is enriched in the bodies of
genes with CpG island promoters
In contrast to H3K36me3, which is located towards the 3’
end of active gene bodies, monomethylation of histone H3
lysine 36 (H3K36me1) is detected in the 5’ end of highly
expressed genes [46]. Surprisingly, our analysis suggests
that H3K36 monomethylation is only enriched in the
bodies of active genes that have CpG islands in their pro-
moters (Figure 4a). Enrichment is detected on the fourth
to eighth nucleosomes downstream of the start site, and
then quickly returns to background levels within 2 kb
(Figure 4a). In contrast, no enrichment is detected in
highly expressed non-CpG promoter genes (Figure 4a).
This suggests that the deposition of this modification may
depend on the presence of a CpG island.
Some transcription-associated histone modifications are
depleted in the 5’ ends of CpG promoter genes
In contrast to the histone modifications described above
that are shifted closer to the transcription start site in CpG
promoter genes (H4K20me1, H2BK5me1, H3K79me1/2/3),
show stronger peaks that shift in location in CpG promoter
genes (H3K9me1, H3K4me1, H3K4me2, H3K27me1), or
are only enriched in CpG promoter genes (H3K36me1), a
fourth set of modifications consists of transcription-asso-
ciated modifications that are actually depleted in the 5’ end
of CpG island promoter genes. In highly expressed genes
with CpG promoters, the modifications H2AK5ac,
H3K14ac and H3K23ac peak approximately 750 bp after
Figure 3 Transcription-coupled shifts of histone modification peaks enriched in the 5’ end of CpG promoter genes. (a-h) Average
profiles of expression-matched CpG and non-CpG genes (a, c, e, g) and heat maps of all genes (b, d, f, h) for H3K9me1 (a, b), H3K4me2 (c, d),
H3K4me1 (e,f) and H3K27me1 (g, h). In the heatmaps, each row represents one gene and each column a single nucleotide position. (i-l) Plots of
the correlation between expression level and peak modification position for H3K9me1 (i), H3K4me2 (j), H3K4me1 (k), H3K27me1 (l) at CpG and
non-CpG promoter genes. The x-axis indicates the first position with the highest histone modification level within 2 kb of the gene transcription
start site (TSS). The y-axis indicates the expression level ranking of the gene. For a direct comparison, only the expression-matched subsets of
genes with low, medium and high expression are plotted here. The spearman rank correlation values are shown below the scatter plots (all P-
values < 10-8).
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the initiation site (Figure 4b-d). In contrast, in non-CpG
genes, these modifications either peak immediately after
the start site (Figure 4c, d) or do not show a clear peak (Fig-
ure 4b). Thus, some transcription activation-associated his-
tone modifications are depleted proximal to the start site of
CpG promoter genes.
A characteristic series of histone modification peaks
means that the relative positions of histone modifications
differ between genes with and without CpG island
promoters
In expressed genes with CpG islands in their promoters,
there is therefore a series of characteristic transitions in
transcription-associated histone modifications in the region
between approximately 0.5 and 2 kb after the initiation site.
In contrast, in non-CpG genes, the same modifications gra-
dually increase more distally within the gene body
(H4K20me1, H2BK5me1, H3K79me1/2/3), show weaker or
no enrichment within the gene body (H3K9me1,
H3K4me1, H3K4me2, H3K27me1, H3K36me1), or are
enriched from immediately after the initiation site
(H2AK5ac, H3K14ac, H3K23ac). Thus, the identity, posi-
tioning, shape and relative ordering of transcription-asso-
ciated histone modifications all differ between genes with
and without CpG island promoters (Figures 2 to 4).
Intrinsic binding preferences only predict nucleosome
occupancy in non-expressed, non-CpG island promoters
We next compared overall levels of nucleosome occu-
pancy within CpG and non-CpG promoter genes, as
revealed by micrococcal nuclease digestion [49] (Figure 5).
For highly expressed genes, patterns of occupancy are
similar in the two gene classes: a characteristic nucleo-
some-depleted region is observed upstream of the tran-
scription start site, and an array of well-positioned
nucleosomes within the 5’ end of the gene (Figure 5a).
From an analysis of all genes it was previously proposed
that nucleosome depletion upstream of transcription start
sites is independent of gene expression level [49]. Our ana-
lysis showed that this is indeed the case for CpG promo-
ters (Figure 5a), but for non-CpG promoters there is a
clear association between a nucleosome-depleted region
and mRNA expression levels (Figure 5a). That is, CpG
promoters have a constitutive nucleosome-depleted
region, but non-CpG promoters do not.
Moreover, comparing the nucleosome occupancy
detected in human promoters to that predicted by the
intrinsic binding preferences of nucleosomes for DNA [50]
revealed that only in non-expressed, non-CpG promoters
is nucleosome occupancy actually reflecting the intrinsic
binding preferences of nucleosomes for DNA (Figure 5a,
b). Thus, in contrast to the situation in transcriptionally
quiescent sperm [51], in somatic cells influences beyond
the affinity of the DNA for nucleosomes must be impor-
tant for determining nucleosome occupancy in most active
and repressed human promoters.
Evidence for an unstable H4K20me3-modified
nucleosome at the start site in active CpG island
promoters
Consistent with the overall nucleosome depletion, most
histone modifications are also depleted at the transcription
start sites of CpG promoter genes and at the start sites of
highly expressed non-CpG promoter genes (Figures 3, 4
and 6). However, our analysis revealed one notable excep-
tion to this: the modification H4K20me3 is detected pre-
cisely at the transcription start site in active CpG
promoters (Figure 5c). This signal is weak but detected
across many initiation sites (Figure 5d). With the current
data, we cannot exclude the possibility that the signal is
coming from a subset of cells within the population.
Nevertheless, a similar peak is not seen for other modifica-
tions (Additional file 3). Previously, H4K20me3 has been
Figure 4 Some transcription-associated histone modifications
are depleted in the 5’ ends of CpG promoter genes. (a-d)
Average profiles of expression-matched CpG and non-CpG genes
for H3K36me1 (a), H2AK5ac (b), H3K14ac (c), and H3K23ac (d).
Arrows indicate modification peaks unique to CpG promoter genes.
TSS, transcription start site.
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linked to transcriptional pausing [52], to heterochromatin
[53], and to the body of KRAB and zinc finger genes
[39,46]. Our analysis suggests that the modification is also
specifically enriched on an unstable nucleosome precisely
positioned at the transcription start site in active CpG
island promoters. To our knowledge, this is the first evi-
dence for a specific histone post-translational modification
precisely marking transcription start sites.
Transcription-associated epigenetic asymmetries around
start sites
Many epigenetic modifications, particularly histone acet-
ylations, are enriched around the start sites of actively
expressed genes (Additional file 3). One of these start
site-proximal modifications, H3K4me3, was previously
reported to show two distinct peaks in the forward and
reverse directions, interpreted as corresponding to two
divergent sites of RNA polymerase II initiation [16]. Our
expression-matched gene sets show that these dual peaks
are observed for many promoter-associated
modifications, and for both CpG and non-CpG promoter
genes (Figure 6a, b). Interestingly, however, the symmetry
of these dual peaks about the start site can differ between
CpG and non-CpG promoters. For example, the modifi-
cations H2A.Z and H4K5ac (and to a lesser extent
H4K8ac, H3K36ac, H3K27ac, H2BK5ac, H3K18ac,
H3K9ac and H3K4me3) actually have higher levels
upstream of the start site (in the antisense orientation)
than downstream (in the sense orientation) specifically in
promoters with CpG islands (Figure 6). This difference is
characteristic comparing across promoters (Figure 6) and
again points to a different transcription-associated chro-
matin organization in genes with CpG island promoters.
The chromosome organization factor CTCF may be bound
immediately upstream of RNA polymerase II in most
active CpG island promoters
Finally, we examined the association of the chromosome
organization CCTC-binding factor (CTCF) with CpG
and non-CpG promoter genes, and how this association
Figure 5 CpG promoters have a constitutive nucleosome-depleted region and, when active, an unstable H4K20me3-modified
nucleosome at the start site. (a, b) Highly expressed CpG promoter and non-CpG promoter genes have an upstream nucleosome-depleted
region and well-positioned nucleosomes within the gene body (a, top). However, CpG promoters also contain a nucleosome-depleted region
when repressed (a, bottom left) whereas, in inactive non-CpG promoters (a, bottom right), nucleosome occupancy more closely resembles that
predicted by the intrinsic binding preferences of nucleosomes for DNA (b). (c, d) In expressed CpG promoter genes the transcription initiation
site within the nucleosome-depleted region (a) is precisely marked by H4K20me3.
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relates to gene expression. We chose to analyze CTCF
because up to a quarter of all binding sites for CTCF
have been reported to occur close to gene promoters
[46,54]. Surprisingly, CTCF is detected at high levels
immediately upstream of the start site in very many CpG
island promoters (Figure 7a, b; Additional file 10), and at
similar levels in genes with both medium and high
expression (and medium and high levels of RNA poly-
merase II; Figure 7c, d). This suggests the intriguing pos-
sibility that CTCF binding might be part of the general
architecture of an active CpG island promoter (see
Discussion).
Discussion
We have presented here evidence that, depending upon
the type of promoter in which transcription initiates,
human genes show two distinct patterns of transcription-
coupled changes in chromatin organization. Transcrip-
tion from both CpG and non-CpG promoters is asso-
ciated with a set of histone-modification transitions
around the start site and into the gene body, but the
identity, shape and ordering of these modifications differs
between the two gene classes. These differences are sum-
marized in Figure 8.
In the repressed state, CpG promoters are distinguished
by a nucleosome-depleted region. Upon activation, this
nucleosome-depleted region shows evidence of containing
a nucleosome specifically modified by H4K20me3 at the
initiation site, and CTCF binds immediately upstream of
RNA polymerase. This suggests that CTCF could be part
of the basic architecture of CpG island promoters, perhaps
contributing to their organization into ‘active chromatin
hubs’ or ‘transcription factories’ [55,56].
Multiple transcription elongation-coupled modifications
(H4K20me1, H2BK5me1, H3K79me1/2/3) occur on
nucleosomes closer to the transcription start site in genes
with CpG promoters, suggesting an earlier and sharper
transition in transcription elongation complexes. In con-
trast, a later elongation complex transition, as reflected in
the deposition of H3K36me3, appears to occur indepen-
dently of promoter type. H3K36me1 appears specific to
CpG promoter genes, and H3K9me1, H3K4me1, H3K4me2
and H3K27me1 show stronger transcription-associated
peaks in the 5’ ends of these genes. Uniquely, the same
modifications also shift into the bodies of genes as expres-
sion levels increase: the most modified nucleosomes are dif-
ferent in genes with high and low expression levels. This
might, perhaps, reflect incompatibility with other modifica-
tions detected in higher levels close to the start site in highly
active genes. Finally, other transcription-coupled modifica-
tions (H2AK5ac, H3K14ac, H3K23ac) are depleted in the
very 5’ end of CpG promoter genes. It is possible that
enzymes removing these modifications are directly or indir-
ectly recruited to CpG islands, as has been shown for the
CXXC domain-containing H3K36me2 demethylase
KDM2A [57].
Conclusions
Taken together, therefore, we propose that active CpG pro-
moter genes have a characteristic ‘step-like’ series of transi-
tions in the modifications that nucleosomes carry
upstream, downstream, and at the transcription initiation
site, extending about 2 kb into a gene (Figure 8). Several
potential molecular mechanisms could contribute to this
characteristic chromatin signature. Possibilities include the
direct recruitment of histone-modifying enzymes to CpG
Figure 6 Asymmetries in promoter proximal histone modifications around the transcription start site. (a,b) H2A.Z (a) and H4K5ac (b)
have higher modification levels upstream of the start site of CpG promoter genes. (c) The asymmetry of each promoter proximal modification is
quantified for all highly expressed CpG (red) and non-CpG (blue) promoter genes. Here the number of modified histone reads between the
transcription start site (TSS) and 500 bp upstream of the start site is divided by the number of reads between the start site and 500 bp
downstream. Box plots indicate the range and 25, 50 and 75 percentile of the asymmetry score for the 500 highly expressed genes. Significant
differences in the distributions between CpG and non-CpG promoter genes are indicated by an asterisk (Wilcoxon signed rank test, P < 0.05).
Vavouri and Lehner Genome Biology 2012, 13:R110
http://genomebiology.com/2012/13/11/R110
Page 7 of 12
islands, a difference in the composition of RNA polymerase
complexes loading in CpG island promoters, or altered
dynamics of polymerase, such as delayed release from the
promoter and different elongation speeds. CpG promoters
often transcribe non-coding RNAs, and it is possible that
some chromatin differences relate to the recruitment of
chromatin-modifying enzymes by these RNAs [58]. The
interplay between different modifications is also likely to be
important: both the sequential recruitment of ‘reader’ and
‘writer’ proteins away from the start site and the incompat-
ibility between different modifications could contribute to
the establishment of the characteristic nucleosome series.
For example, increased acetylase recruitment at the start
site may contribute to the 3’ shift in histone methylations
in highly expressed CpG promoter genes. In future work,
biochemical studies will be required to investigate these
possible molecular mechanisms. Together with previous
work, however, our results suggest that the chromatin
organization of a human gene reflects not just the level of
expression, but also the type of promoter in which tran-
scription initiates.
Materials and methods
Gene start site and CpG island annotations
Human protein-coding genes were retrieved from
Ensembl release 54 [59]. For each gene we considered
Figure 7 CTCF is bound immediately upstream of RNA polymerase in active CpG island promoters. (a-d) CTCF is bound immediately
upstream of the initiation site, with similar recruitment in CpG genes with high and medium expression (a, b) and with high and low RNA



























Figure 8 Human genes with CpG promoters show distinct transcription-coupled changes in chromatin. (a) Multiple transcription
elongation-associated histone modifications are detected on nucleosomes closer to the transcription start site (TSS) in genes with CpG islands in
their promoters (orange) compared to other genes (green). (b) In contrast, other transcription-associated histone modifications are excluded
from a promoter proximal region. (c) H3K36me1 is only detected in the bodies of genes with CpG promoters. (d) Additional transcription-
associated modifications are enriched in CpG promoter genes and shift in location away from the start as expression levels increase. (e) Taken
together, this means that genes with CpG promoters show a characteristic series of modified nucleosomes upstream, downstream, and at the
transcription start site.
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only the most 5’ transcription start site and we removed
genes less than 3 kb long to avoid the inclusion of non-
genic regions downstream of a gene. To avoid analyzing
upstream regions that overlap another gene, we also
removed all genes that have a promoter within 500 bp of
another gene. We retrieved CpG islands from the UCSC
genome browser [5,60]. We considered a gene as having
a CpG-island promoter when its first transcription start
site overlaps a UCSC CpG island. Removing genes with
more than one transcription start site did not change any
of the observations (see Additional file 8). All chromatin
profiles were repeated using the alternative CpG island
definition from [48] (shown in Additional file 6). Further,
all chromatin profiles were repeated using the promoter
definition by [25] (shown in Additional file 7). Following
the original definition, to annotate promoters as ‘high
CpG promoters’ (HCPs) we scanned the region from
-1,200 bp to +300 bp of the transcription start site for a
500-bp window with CpG observed over expected ratio
of > 0.75 and GC content > 55. Promoters with all win-
dows with CpG observed over expected ratio ≤ 0.48 were
annotated as ‘low CpG promoters’ (LCPs). The rest of
the promoters were annotated as ‘intermediate CpG pro-
moters’ (ICPs).
Gene expression data
We retrieved MAS5 normalized mRNA expression data
for CD4+ T cells from Schones et al. [49] (Gene Expres-
sion Omnibus (GEO) accession GSE10437), mapping
U133-PLUS-2 probes to genes using Ensembl. Probes
matching multiple genes were discarded. In total, 16,781
protein-coding genes had annotated expression levels.
Genes were ranked according to their expression level,
using the (replicate-averaged) value of the most sensitive
probe. We then split all genes into three equally sized
groups of genes according to their expression level (low,
middle and high expression). From these we randomly
sampled 500 low, 500 intermediate and 500 high expres-
sion non-CpG promoter genes. For each non-CpG promo-
ter gene we then identified a CpG promoter gene with a
very similar expression level (absolute difference between
loge expression of non-CpG promoter gene and loge
expression of CpG promoter gene ≤ 0.1). These three
expression-matched sets of CpG and non-CpG promoter
genes were used to generate average chromatin profile
plots. The entire sets of high, intermediate and low expres-
sion genes were used to generate chromatin profile heat-
maps (the number of genes in each class are included in
Additional file 1). The expression-matched sets of genes
and their annotations are included in Additional file 2. A
small number of genes with extreme expression levels for
which we could not find a similarly expressed gene with a
different promoter type were removed. We repeated the
analysis in exactly the same way for IMR90 cells using
microarray gene expression data from Kim et al. [36]
(GEO accession GSE2672).
Chromatin profiles
We retrieved the mapped sequenced reads of nucleosome
fragments [49] and ChIP-Seq mapped read data for H2A.Z,
20 histone methylations [46] and 18 histone acetylations
[38]. Similarly, we analyzed DNA methylation data from
the same cell-type [61]. These datasets contained all reads
that match the genome in a unique position with up to
two mismatches. To minimize sequence amplification bias,
we removed identical reads. We shifted the start position
of the reads by 75 bp in the direction of sequencing (75 bp
is approximately half of the length of the isolated DNA
fragments), this way transforming the read start positions
to nucleosome dyad positions. All datasets were rescaled to
10 million uniquely mapped nucleosome fragments. To
generate the average chromatin profiles shown in the fig-
ures, we counted the number of dyads that fall at each
position along the region surrounding the gene start site.
Smoothed lines were generated based on the per-base-pair
averaged position-shifted read count using the loess regres-
sion function in R (with 180 bp span) [62]. The predict.
loess R function was used for the calculation of 95% confi-
dence intervals. For the background subtracted chromatin
profiles included in Additional file 3 we used a 75-bp win-
dow sliding by 1 bp and calculated the difference between
the number of shifted reads from the histone modification
(or H2A.Z) and the number of shifted reads from the
nucleosome occupancy. At each position with respect to
the transcription start site we then calculated the mean
and the standard error of the background-subtracted values
assuming a Normal distribution. Heatmaps were generated
using Java Tree View 1.1.5r2 [63]. We repeated all chroma-
tin profiles using data from a fetal lung fibroblast cell line
(IMR90) generated by the NIH Roadmap Epigenomics Pro-
ject [64,65]. We downloaded the mapped reads provided as
BED files. Because these reads were mapped to human
genome version hg19, we converted all gene promoters
from hg18 to hg19 using the LiftOver tool. These profiles
are shown in Additional file 9. The accession identifiers of
the samples used for these profiles are included in the fig-
ure legend. Regions of statistically significant CTCF bind-
ing in CD4+ T cells (used in Additional file 10), based on
the data from Barski et al. [46], were retrieved from
Ensembl (regulatory build of Ensembl release 68). We
defined distal CTCF binding sites as those not overlapping
any annotated Ensembl gene. The coordinates of CTCF
peaks were converted from human genome assembly hg19
to hg18 using the liftOver tool [60].
Sequence properties
Intrinsic nucleosome binding preference calculations
along the human genome were predicted by Kaplan et
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al. and downloaded from the authors’ website [50]. The
average nucleosome affinity model score around the
transcription start site of each gene set is shown in Fig-
ure 5b. We also carried out the same analysis using the
predicted probability that a nucleosome will be formed
at each genomic position [50], which gave very similar
results (data not shown). Similarly, as a control, we also
calculated the G+C content profile at ± 3 kb around the
gene start of each group (Additional file 11).
Histone modification peak positions and asymmetry
around the gene start
To compare the asymmetry of a histone modification
around the start of CpG promoter and non-CpG pro-
moter genes, for each highly expressed gene we calcu-
lated the number of position-shifted reads that map to
the 500 bp upstream of the gene start and divided by
the total number of position-shifted reads that map
within 500 bp both upstream and downstream of the
gene start. We then compared the distributions of these
‘asymmetry scores’ at highly expressed CpG and non-
CpG promoter genes using the Wilcoxon rank sum test.
Additional material
Additional file 1: Table with gene groups classified according to
promoter type and gene expression level. Excel file containing
human genes classified according to their promoter type and their
expression level in CD4+ T cells and IMR90 cells.
Additional file 2: Table with the expression-matched groups of CpG
and non-CpG promoter genes. Excel file containing the Ensembl
identifiers of genes and the corresponding expression values used to
generate all the average chromatin profile plots in the main figures.
Additional file 3: Average background subtracted chromatin
profiles of all histone modifications and H2A.Z at expression-
matched CpG and non-CpG promoter genes. Grey shading indicates
the 95% confidence interval of the calculated mean.
Additional file 4: Exon density profiles of the expression-matched
CpG and non-CpG promoter genes.
Additional file 5: DNA methylation profiles at expression-matched
CpG and non-CpG promoter genes.
Additional file 6: Chromatin profiles of genes annotated according
to whether they overlap CpG islands defined by the CpGcluster
program [48].
Additional file 7: Chromatin profiles of genes grouped into three
promoter types: high CpG promoters, intermediate CpG promoters
and low CpG promoters. For this supplementary figure, we annotated
genes based on their promoter type using the definition of Weber et al.
[25]. We sampled 300 genes from each expression level and each
promoter type to generate the average chromatin profile plots.
Additional file 8: Chromatin profiles of genes that contain a single
transcription start site. For this supplementary figure, we removed all
genes with more than one transcription start site. We then split the
genes into the three expression levels and sampled 300 genes from each
expression level and each promoter type to generate the average
chromatin profile plots. Promoters are annotated according to UCSC
downloaded CpG islands [5].
Additional file 9: Chromatin profiles of expression-matched CpG
and non-CpG promoter genes in IMR90 cells. Note that the CD4+ T-
cell chromatin profiles shown in the main paper and the IMR90
chromatin datasets shown here were generated with different chromatin
immunoprecipitation protocols. In the case of CD4+ T cells, nucleosomes
were isolated by micrococcal nuclease digestion before
immunoprecipitation. In the case of IMR90 cells, chromatin was sonicated
before immunoprecipitation. These experimental differences may
account for some of the differences in the CD4+ T-cell chromatin profiles
and the IMR90 chromatin profiles. The GEO file accession numbers for
the datasets used here are GSE2672 (a), GSM521890 (b), GSM521915 (c),
GSM521904 (d), GSM752986 (e), GSM521899 (f), GSM521895 (g),
GSM521866 (h), GSM521881 (i), GSM521885 (j), GSM469975 (k). Promoters
are annotated according to UCSC downloaded CpG islands [5].
Additional file 10: CTCF binds CpG promoters more frequently than
non-CpG promoters. (a-f) CpG promoters are more frequently bound by
CTCF than non-CpG promoters. The enrichment of CTCF at CpG promoters
is independent of the definition of overlap (a, c, e). All comparisons have a
chi-squared test P-value < 2.2e-16. To control for the correlation between
CTCF binding and expression level, we split the two groups of genes into
ten equally sized expression bins and counted the fraction of promoters
overlapping CTCF binding sites in each expression bin (b, d, f). Error bars
represent 95% confidence intervals of binomial proportions. (g-i) CTCF
binding sites that overlap CpG promoters have similar levels of CTCF as
intergenic CTCF binding sites. Here we show CTCF levels at all CpG
promoters (g), CTCF levels at an equal number of distal CTCF binding sites
(h) and CTCF levels at all intergenic CTCF binding sites (i). The CTCF profiles
shown in (g-i) are centered on the CTCF peak mid-point.
Additional file 11: GC content around CpG and non-CpG promoter
genes.
Abbreviations
bp: base pair; GEO: Gene Expression Omnibus.
Acknowledgements
TV is funded by MICINN grant BFU2011-30246, Ramon y Cajal grant RYC-
2010-07114, European Commission Framework 7 European Re-integration
grant PERG08-GA-2010-276741, and by the Institute of Predictive and
Personalized Medicine of Cancer. BL is funded by an ERC Starting Grant,
ERASysBio+ ERANET, MICINN grant BFU2008-00365, AGAUR, the EMBO
Young Investigator Program, European Commission Framework 7 integrated
project 4DCellFate, and by the EMBL-CRG Systems Biology Program. We
thank Salvador Aznar Benitah and Luciano di Croce for comments on the
manuscript.
Author details
1Institute of Predictive and Personalized Medicine of Cancer (IMPPC),
Badalona, Barcelona 08916, Spain. 2EMBL-CRG Systems Biology Unit and
ICREA, Centre for Genomic Regulation and UPF, Barcelona 08003, Spain.
Authors’ contributions
TV performed all analyses. TV and BL designed analyses and wrote the
manuscript. Both authors read and approved the manuscript for publication.
Competing interests
The authors declare that they have no competing interests.
Received: 5 July 2012 Revised: 15 October 2012
Accepted: 27 November 2012 Published: 27 November 2012
References
1. Illingworth RS, Bird AP: CpG islands - ‘A rough guide’. FEBS Lett 2009,
583:1713-1720.
2. Mohn F, Schubeler D: Genetics and epigenetics: stability and plasticity
during cellular differentiation. Trends Genet 2009, 25:129-136.
3. Bird AP: DNA methylation and the frequency of CpG in animal DNA.
Nucleic Acids Res 1980, 8:1499-1504.
4. Bird A, Taggart M, Frommer M, Miller OJ, Macleod D: A fraction of the
mouse genome that is derived from islands of nonmethylated, CpG-rich
DNA. Cell 1985, 40:91-99.
Vavouri and Lehner Genome Biology 2012, 13:R110
http://genomebiology.com/2012/13/11/R110
Page 10 of 12
5. Gardiner-Garden M, Frommer M: CpG islands in vertebrate genomes. J
Mol Biol 1987, 196:261-282.
6. Saxonov S, Berg P, Brutlag DL: A genome-wide analysis of CpG
dinucleotides in the human genome distinguishes two distinct classes
of promoters. Proc Natl Acad Sci USA 2006, 103:1412-1417.
7. Cohen NM, Kenigsberg E, Tanay A: Primate CpG islands are maintained by
heterogeneous evolutionary regimes involving minimal selection. Cell
2011, 145:773-786.
8. Larsen F, Gundersen G, Lopez R, Prydz H: CpG islands as gene markers in
the human genome. Genomics 1992, 13:1095-1107.
9. Ponger L, Duret L, Mouchiroud D: Determinants of CpG islands:
expression in early embryo and isochore structure. Genome Res 2001,
11:1854-1860.
10. Zhu J, He F, Hu S, Yu J: On the nature of human housekeeping genes.
Trends Genet 2008, 24:481-484.
11. Ramskold D, Wang ET, Burge CB, Sandberg R: An abundance of
ubiquitously expressed genes revealed by tissue transcriptome
sequence data. PLoS Comput Biol 2009, 5:e1000598.
12. Tanay A, O’Donnell AH, Damelin M, Bestor TH: Hyperconserved CpG
domains underlie Polycomb-binding sites. Proc Natl Acad Sci USA 2007,
104:5521-5526.
13. Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic J,
Semple CAM, Taylor MS, Engström PG, Frith MC, Forrest ARR, Alkema WB,
Tan SL, Plessy C, Kodzius R, Ravasi T, Kasukawa T, Fukuda S, Kanamori-
Katayama M, Kitazume Y, Kawaji H, Kai C, Nakamura M, Konno H, Nakano K,
Mottagui-Tabar S, Arner P, Chesi A, Gustincich S, Persichetti F, et al:
Genome-wide analysis of mammalian promoter architecture and
evolution. Nat Genet 2006, 38:626-635.
14. Core LJ, Waterfall JJ, Lis JT: Nascent RNA sequencing reveals widespread
pausing and divergent initiation at human promoters. Science 2008,
322:1845-1848.
15. Preker P, Nielsen J, Kammler S, Lykke-Andersen S, Christensen MS,
Mapendano CK, Schierup MH, Jensen TH: RNA exosome depletion reveals
transcription upstream of active human promoters. Science 2008,
322:1851-1854.
16. Seila AC, Calabrese JM, Levine SS, Yeo GW, Rahl PB, Flynn RA, Young RA,
Sharp PA: Divergent transcription from active promoters. Science 2008,
322:1849-1851.
17. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA: A chromatin
landmark and transcription initiation at most promoters in human cells.
Cell 2007, 130:77-88.
18. Rozenberg JM, Shlyakhtenko A, Glass K, Rishi V, Myakishev MV,
Fitzgerald PC, Vinson C: All and only CpG containing sequences are
enriched in promoters abundantly bound by RNA polymerase II in
multiple tissues. BMC Genomics 2008, 9:67.
19. Rahl PB, Lin CY, Seila AC, Flynn RA, Mccuine S, Burge CB, Sharp PA,
Young RA: c-Myc regulates transcriptional pause release. Cell 2010,
141:432-445.
20. Megraw M, Pereira F, Jensen ST, Ohler U, Hatzigeorgiou AG: A transcription
factor affinity-based code for mammalian transcription initiation.
Genome Res 2009, 19:644-656.
21. Voo KS, Carlone DL, Jacobsen BM, Flodin A, Skalnik DG: Cloning of a
mammalian transcriptional activator that binds unmethylated CpG
motifs and shares a CXXC domain with DNA methyltransferase, human
trithorax, and methyl-CpG binding domain protein 1. Mol Cell Biol 2000,
20:2108-2121.
22. Thomson JP, Skene PJ, Selfridge J, Clouaire T, Guy J, Webb S, Kerr AR,
Deaton A, Andrews R, James KD, Turner DJ, Illingworth R, Bird A: CpG
islands influence chromatin structure via the CpG-binding protein Cfp1.
Nature 2010, 464:1082-1086.
23. Blackledge NP, Zhou JC, Tolstorukov MY, Farcas AM, Park PJ, Klose RJ: CpG
islands recruit a histone H3 lysine 36 demethylase. Mol Cell 2010,
38:179-190.
24. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P,
Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O’Donovan A,
Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C,
Lander ES, Bernstein BE: Genome-wide maps of chromatin state in
pluripotent and lineage-committed cells. Nature 2007, 448:553-560.
25. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M,
Schubeler D: Distribution, silencing potential and evolutionary impact of
promoter DNA methylation in the human genome. Nat Genet 2007,
39:457-466.
26. Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR,
Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, Kuehn MS,
Taylor CM, Neph S, Koch CM, Asthana S, Malhotra A, Adzhubei I,
Greenbaum JA, Andrews RM, Flicek P, Boyle PJ, Cao H, Carter NP,
Clelland GK, Davis S, Day N, Dhami P, Dillon SC, Dorschner MO, Fiegler H,
et al: Identification and analysis of functional elements in 1% of the
human genome by the ENCODE pilot project. Nature 2007, 447:799-816.
27. Bhandare R, Schug J, Le Lay J, Fox A, Smirnova O, Liu C, Naji A,
Kaestner KH: Genome-wide analysis of histone modifications in human
pancreatic islets. Genome Res 2010, 20:428-433.
28. Mendenhall EM, Koche RP, Truong T, Zhou VW, Issac B, Chi AS, Ku M,
Bernstein BE: GC-rich sequence elements recruit PRC2 in mammalian ES
cells. PLoS Genet 2010, 6:e1001244.
29. Tillo D, Kaplan N, Moore IK, Fondufe-Mittendorf Y, Gossett AJ, Field Y,
Lieb JD, Widom J, Segal E, Hughes TR: High nucleosome occupancy is
encoded at human regulatory sequences. PLoS One 2010, 5:e9129.
30. Tirosh I, Barkai N: Two strategies for gene regulation by promoter
nucleosomes. Genome Res 2008, 18:1084-1091.
31. Field Y, Kaplan N, Fondufe-Mittendorf Y, Moore IK, Sharon E, Lubling Y,
Widom J, Segal E: Distinct modes of regulation by chromatin encoded
through nucleosome positioning signals. PLoS Comput Biol 2008, 4:
e1000216.
32. Wang X, Xuan Z, Zhao X, Li Y, Zhang MQ: High-resolution human core-
promoter prediction with CoreBoost_HM. Genome Res 2009, 19:266-275.
33. Karlic R, Chung HR, Lasserre J, Vlahovicek K, Vingron M: Histone
modification levels are predictive for gene expression. Proc Natl Acad Sci
USA 2010, 107:2926-2931.
34. Bannister AJ, Kouzarides T: Regulation of chromatin by histone
modifications. Cell Res 2011, 21:381-395.
35. Bernstein BE, Humphrey EL, Erlich RL, Schneider R, Bouman P, Liu JS,
Kouzarides T, Schreiber SL: Methylation of histone H3 Lys 4 in coding
regions of active genes. Proc Natl Acad Sci USA 2002, 99:8695-8700.
36. Kim TH, Barrera LO, Zheng M, Qu C, Singer MA, Richmond TA, Wu Y,
Green RD, Ren B: A high-resolution map of active promoters in the
human genome. Nature 2005, 436:876-880.
37. Pokholok DK, Harbison CT, Levine S, Cole M, Hannett NM, Lee TI, Bell GW,
Walker K, Rolfe PA, Herbolsheimer E, Zeitlinger J, Lewitter F, Gifford DK,
Young RA: Genome-wide map of nucleosome acetylation and
methylation in yeast. Cell 2005, 122:517-527.
38. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, Cui K,
Roh TY, Peng W, Zhang MQ, Zhao K: Combinatorial patterns of histone
acetylations and methylations in the human genome. Nat Genet 2008,
40:897-903.
39. Ernst J, Kellis M: Discovery and characterization of chromatin states for
systematic annotation of the human genome. Nat Biotechnol 2010,
28:817-825.
40. Schaft D, Roguev A, Kotovic KM, Shevchenko A, Sarov M, Shevchenko A,
Neugebauer KM, Stewart AF: The histone 3 lysine 36 methyltransferase,
SET2, is involved in transcriptional elongation. Nucleic Acids Res 2003,
31:2475.
41. Krogan NJ, Kim M, Tong A, Golshani A, Cagney G, Canadien V, Richards DP,
Beattie BK, Emili A, Boone C: Methylation of histone H3 by Set2 in
Saccharomyces cerevisiae is linked to transcriptional elongation by RNA
polymerase II. Mol Cell Biol 2003, 23:4207.
42. Li J, Moazed D, Gygi SP: Association of the histone methyltransferase
Set2 with RNA polymerase II plays a role in transcription elongation. J
Biol Chem 2002, 277:49383.
43. Hon G, Wang W, Ren B: Discovery and annotation of functional
chromatin signatures in the human genome. PLoS Comput Biol 2009, 5:
e1000566.
44. Li Z, Nie F, Wang S, Li L: Histone H4 Lys 20 monomethylation by histone
methylase SET8 mediates Wnt target gene activation. Proc Natl Acad Sci
USA 2011, 108:3116-3123.
45. Congdon LM, Houston SI, Veerappan CS, Spektor TM, Rice JC: PR-Set7-
mediated monomethylation of histone H4 lysine 20 at specific genomic
regions induces transcriptional repression. J Cell Biochem 2010,
110:609-619.
Vavouri and Lehner Genome Biology 2012, 13:R110
http://genomebiology.com/2012/13/11/R110
Page 11 of 12
46. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G,
Chepelev I, Zhao K: High-resolution profiling of histone methylations in
the human genome. Cell 2007, 129:823-837.
47. Vakoc CR, Sachdeva MM, Wang H, Blobel GA: Profile of histone lysine
methylation across transcribed mammalian chromatin. Mol Cell Biol 2006,
26:9185-9195.
48. Hackenberg M, Previti C, Luque-Escamilla PL, Carpena P, Martinez-Aroza J,
Oliver JL: CpGcluster: a distance-based algorithm for CpG-island
detection. BMC Bioinformatics 2006, 7:446.
49. Schones DE, Cui K, Cuddapah S, Roh TY, Barski A, Wang Z, Wei G, Zhao K:
Dynamic regulation of nucleosome positioning in the human genome.
Cell 2008, 132:887-898.
50. Kaplan N, Moore IK, Fondufe-Mittendorf Y, Gossett AJ, Tillo D, Field Y,
LeProust EM, Hughes TR, Lieb JD, Widom J, Segal E: The DNA-encoded
nucleosome organization of a eukaryotic genome. Nature 2009,
458:362-366.
51. Vavouri T, Lehner B: Chromatin organization in sperm may be the major
functional consequence of base composition variation in the human
genome. PLoS Genet 2011, 7:e1002036.
52. Kapoor-Vazirani P, Kagey JD, Vertino PM: SUV420H2-mediated H4K20
trimethylation enforces RNA polymerase II promoter-proximal pausing
by blocking hMOF-dependent H4K16 acetylation. Mol Cell Biol 2011,
31:1594-1609.
53. Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G, Reinberg D,
Jenuwein T: A silencing pathway to induce H3-K9 and H4-K20
trimethylation at constitutive heterochromatin. Genes Dev 2004,
18:1251-1262.
54. Kim TH, Abdullaev ZK, Smith AD, Ching KA, Loukinov DI, Green RD,
Zhang MQ, Lobanenkov VV, Ren B: Analysis of the vertebrate insulator
protein CTCF-binding sites in the human genome. Cell 2007,
128:1231-1245.
55. de Laat W, Grosveld F: Spatial organization of gene expression: the active
chromatin hub. Chromosome Res 2003, 11:447-459.
56. Edelman LB, Fraser P: Transcription factories: genetic programming in
three dimensions. Curr Opin Genet Dev 2012, 22:110-114.
57. Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH,
Tempst P, Zhang Y: Histone demethylation by a family of JmjC domain-
containing proteins. Nature 2006, 439:811-816.
58. Kanhere A, Viiri K, Araujo CC, Rasaiyaah J, Bouwman RD, Whyte WA,
Pereira CF, Brookes E, Walker K, Bell GW, Pombo A, Fisher AG, Young RA,
Jenner RG: Short RNAs are transcribed from repressed polycomb target
genes and interact with polycomb repressive complex-2. Mol Cell 2010,
38:675-688.
59. Flicek P, Amode MR, Barrell D, Beal K, Brent S, Chen Y, Clapham P, Coates G,
Fairley S, Fitzgerald S: Ensembl 2011. Nucleic Acids Res 2011, 39:D800.
60. Rhead B, Karolchik D, Kuhn RM, Hinrichs AS, Zweig AS, Fujita PA,
Diekhans M, Smith KE, Rosenbloom KR, Raney BJ, Pohl A, Pheasant M,
Meyer LR, Learned K, Hsu F, Hillman-Jackson J, Harte RA, Giardine B,
Dreszer TR, Clawson H, Barber GP, Haussler D, Kent WJ: The UCSC Genome
Browser database: update 2010. Nucleic Acids Res 2010, 38:D613-619.
61. Choi JK, Bae JB, Lyu J, Kim TY, Kim YJ: Nucleosome deposition and DNA
methylation at coding region boundaries. Genome Biol 2009, 10:R89.
62. R Development Core Team: R: A language and environment for statistical
computing. R Foundation for Statistical Computing, Vienna, Austria;[http://
www.r-project.org/].
63. Saldanha AJ: Java Treeview–extensible visualization of microarray data.
Bioinformatics 2004, 20:3246-3248.
64. Hawkins RD, Hon GC, Lee LK, Ngo Q, Lister R, Pelizzola M, Edsall LE, Kuan S,
Luu Y, Klugman S, Antosiewicz-Bourget J, Ye Z, Espinoza C, Agarwahl S,
Shen L, Ruotti V, Wang W, Stewart R, Thomson JA, Ecker JR, Ren B: Distinct
epigenomic landscapes of pluripotent and lineage-committed human
cells. Cell Stem Cell 2010, 6:479-491.
65. Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A,
Meissner A, Kellis M, Marra MA, Beaudet AL, Ecker JR, Farnham PJ, Hirst M,
Lander ES, Mikkelsen TS, Thomson JA: The NIH Roadmap Epigenomics
Mapping Consortium. Nat Biotechnol 2010, 28:1045-1048.
doi:10.1186/gb-2012-13-11-r110
Cite this article as: Vavouri and Lehner: Human genes with CpG island
promoters have a distinct transcription-associated chromatin
organization. Genome Biology 2012 13:R110.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Vavouri and Lehner Genome Biology 2012, 13:R110
http://genomebiology.com/2012/13/11/R110
Page 12 of 12
